BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 3786964)

  • 1. [Effects of vasodilators on pulmonary hypertension].
    Uotani K; Kanamori K; Fujimura M; Mifune J; Taga K; Shimizu M; Hifumi S; Takahashi Y; Azuma H; Tanaka T
    Kokyu To Junkan; 1986 Sep; 34(9):977-83. PubMed ID: 3786964
    [No Abstract]   [Full Text] [Related]  

  • 2. Vasodilators ineffective in secondary pulmonary hypertension.
    Dash H; Ballentine N; Zelis R
    N Engl J Med; 1980 Oct; 303(18):1062-3. PubMed ID: 7421904
    [No Abstract]   [Full Text] [Related]  

  • 3. The acute effects of prostacyclin on pulmonary hemodynamics in patients with pulmonary hypertension secondary to systemic sclerosis.
    Menon N; McAlpine L; Peacock AJ; Madhok R
    Arthritis Rheum; 1998 Mar; 41(3):466-9. PubMed ID: 9506575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pulmonary hypertension in systemic lupus erythematosus: effect of vasodilators on pulmonary hemodynamics.
    Mahowald ML; Weir EK; Ridley DJ; Messner RP
    J Rheumatol; 1985 Aug; 12(4):773-7. PubMed ID: 4057200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Should patients with pulmonary hypertension and increased pulmonary resistance be treated with vasodilators?
    Rich S
    Cardiovasc Clin; 1990; 21(1):265-74; discussion 275-6. PubMed ID: 2199052
    [No Abstract]   [Full Text] [Related]  

  • 6. [Vasodilators in "primary" pulmonary hypertension?].
    Morpurgo M
    G Ital Cardiol; 1990 Feb; 20(2):123-25. PubMed ID: 2328865
    [No Abstract]   [Full Text] [Related]  

  • 7. The response to inhaled nitric oxide in patients with pulmonary artery hypertension is not masked by baseline vasodilator use.
    Krasuski RA; Wang A; Harrison JK; Tapson VF; Bashore TM
    Am Heart J; 2005 Oct; 150(4):725-8. PubMed ID: 16209974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repetitive dosing of intravenous levosimendan improves pulmonary hemodynamics in patients with pulmonary hypertension: results of a pilot study.
    Kleber FX; Bollmann T; Borst MM; Costard-Jäckle A; Ewert R; Kivikko M; Petterson T; Pohjanjousi P; Sonntag S; Wikström G
    J Clin Pharmacol; 2009 Jan; 49(1):109-15. PubMed ID: 18981240
    [No Abstract]   [Full Text] [Related]  

  • 9. The effects of vasodilators in pulmonary hypertension: pulmonary vascular or peripheral vascular?
    Rich S
    Circ Heart Fail; 2009 Mar; 2(2):145-50. PubMed ID: 19808330
    [No Abstract]   [Full Text] [Related]  

  • 10. Acute improved hemodynamics following inhaled iloprost in chronic thromboembolic pulmonary hypertension.
    Krug S; Hammerschmidt S; Pankau H; Wirtz H; Seyfarth HJ
    Respiration; 2008; 76(2):154-9. PubMed ID: 17804899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unpredictable response to vasodilator therapy in primary pulmonary hypertension.
    Schmiedt MI; Shettigar UR; Siddique M; Barbier G; Bialow M; Carranza S
    Int J Clin Pharmacol Ther; 1998 Aug; 36(8):435-40. PubMed ID: 9726697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Vasodilator therapy in pulmonary arterial hypertension of unknown cause (primary)].
    Lupi Herrera E
    Arch Inst Cardiol Mex; 1982; 52(3):189-90. PubMed ID: 7114962
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of pulmonary hypertension with selective pulmonary vasodilators.
    Haj RM; Cinco JE; Mazer CD
    Curr Opin Anaesthesiol; 2006 Feb; 19(1):88-95. PubMed ID: 16547439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of severe pulmonary hypertension during surgery for congenital heart disease.
    Shyamkrishnan KG; Waikar HD; Titus T
    Indian Heart J; 1996; 48(2):159-60. PubMed ID: 8682557
    [No Abstract]   [Full Text] [Related]  

  • 15. [The effects of diltiazem on pulmonary hemodynamics and oxygenation in copd induced pulmonary hypertension].
    Fang B; Wang C; Dai H
    Zhonghua Yi Xue Za Zhi; 1998 Oct; 78(10):779-81. PubMed ID: 11038835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term treatment with oral sildenafil is safe and improves functional capacity and hemodynamics in patients with pulmonary arterial hypertension.
    Michelakis ED; Tymchak W; Noga M; Webster L; Wu XC; Lien D; Wang SH; Modry D; Archer SL
    Circulation; 2003 Oct; 108(17):2066-9. PubMed ID: 14568893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effects of vasodilators on tissue oxygenation of patients with pulmonary hypertension].
    Yamamoto H; Kado T; Nakata H; Fujii H; Fukuzaki H
    Nihon Kyobu Shikkan Gakkai Zasshi; 1987 Oct; 25(10):1065-71. PubMed ID: 3441074
    [No Abstract]   [Full Text] [Related]  

  • 18. Hope in primary pulmonary hypertension.
    Reeves JT
    N Engl J Med; 1980 Jan; 302(2):112-3. PubMed ID: 7350416
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparison of acute hemodynamic responses to prostacyclin with standard vasodilators in patients with primary pulmonary hypertension.
    Palevsky HI; Fishman AP
    Chest; 1988 Mar; 93(3 Suppl):179S. PubMed ID: 3277819
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of vasodilators on pulmonary vascular resistance in patients with pulmonary hypertension.
    Zaloga GP; Chernow B; Holt MR; Hughes P; Pilley MP; Rainey TG; Lake CR
    Clin Pharm; 1983; 2(3):265-8. PubMed ID: 6192967
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.